Change in Reward System Activation and Gut Microbiota Following RYGB and Sleeve Gastrectomy for Weight Loss vs. Control-Heads Up Ancillary
NCT ID: NCT02735564
Last Updated: 2020-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2016-04-30
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microbiome and Bariatric Surgery
NCT03065426
Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy
NCT03115424
Role of Dietary Habits in Efficacy of Bariatric Surgery - Study C
NCT03482986
Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery
NCT06278285
Adjustable Gastric Banding and Its Effects on Postprandial Glucose Metabolism Independent of Weight Loss
NCT01094054
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RYGB
Bariatric Surgery:Roux-en-y
Bariatric Surgery
SG
Bariatric Surgery: Sleeve Gastrectomy
Bariatric Surgery
Control
BMI matched control
Bariatric Surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bariatric Surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be willing to participate in additional procedures including: 4 brains scans (2 before surgery and 2 after surgery), 2 meal challenges (1 before surgery and 1 after surgery), and 2 microbiota collections (1 before surgery and 1 after surgery).
* Be willing to archive microbiota samples
Control Group:
* Males and females age 21-70 years
* Body Mass Index ≥40 kg/m2 without type 2 diabetes or ≥35 kg/m2 and ≤ 60kg/m² with type 2 diabetes
* Agree to receive frequent contacts from investigators and communicate with program staff for up to 6 months
* Able to give written informed consent
* Able to comply with study procedures
Exclusion Criteria
* Pregnant or planning on becoming pregnant during the 6 months you participate in the study
* History or presence of unremoveable metal objects (medical or dental) or electronic devices or other contraindication to MRI scanning.
* Unwillingness to complete an MRI due to confined space or other related phobias
* Unable or unwilling to give informed consent
* Hospitalization for psychiatric illness or substance use/abuse within the past year
* Diagnosis of schizophrenia, other psychotic disorders, bipolar disorder, or personality disorder as determined by the medical staff
* Travel plans that do not permit participation
* Pregnant or planning on becoming pregnant during the 6 months you participate in the study
* History of prior bariatric surgery, extensive bowel resection, or hiatal hernia repair (unless approved by the medical staff)
* History of eating disorder such as anorexia nervosa, bulimia, or binge eating (unless approved by program staff)
* Current major depressive episode or history of suicidal behaviors
* Severe congestive heart failure (NYHA class III, IV)
* Second degree or greater heart block
* Other medical, psychiatric, or behavioral limitations that in the judgement of the investigator may interfere with program participation or the ability to follow the intervention protocol
* History or presence of unremoveable metal objects (medical or dental) or electronic devices or other contraindication to MRI scanning.
* Unwillingness to complete an MRI due to confined space or other related phobias
21 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pennington Biomedical Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Corby K. Martin
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Keely Hawkins, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Pennington Biomedical Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PBRC 2015-064
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.